Novel Technologies Process Design and Optimization

Expert Support in Advancing Cell, Gene, and Nucleic Acid Therapies
GET STARTED
Lesirg played key roles supporting various companies at the forefront of discovery, research, development, and manufacturing of novel therapies. Our expertise has been particularly valuable in the fields of cell and gene therapies, as well as nucleic acid technologies, where we provide comprehensive guidance and strategic support to help these companies advance breakthrough treatments.
Cell & Gene Therapies
  • Support for facility design to manufacture viral vectors based therapies
  • Process optimization and equipment qualification
  • GMP compliance of facilities, equipment and process commensurate with the product phases
  • RNA sequence design and optimization
  • RNA secondary structure analysis and prediction
  • Suggestion, selection and optimization of corresponding LNP
  • Bioanalytical method development and optimization for RNA product release specifications such as RNA purity and potency analysis, dsRNA analysis, capping efficiency and PolyA tail analytics and others
  • Custom Manufacture of small-scale mRNA and LNPs (micrograms up to a few grams) for R&D and clinical trial purposes
  • Consulting on pre-clinical development
  • Technical feasibility
  • Design of pre-clinical models in novel technologies
  • Scientific data review
  • Due diligence on initial data and study results
  • Assessment of the potential of new technologies
Our consultants include renowned published academics and researchers in mRNA technologies. Clients will benefit from our high-profile technical involvement with multinational initiatives related to RNA research, development and manufacture.

Discover How Lesirg Can Design and Manufacture mRNAs and LNPs for Your Innovative Therapies with Full Analytical Support

CONTACT US
Scroll to Top